Baxter

Deerfield, United States Founded: 1931 • Age: 95 yrs Listed Acquired By Warburg Pincus
Biosciences, medication delivery, and renal products are developed and marketed.

About Baxter

Baxter is a publicly listed company based in Deerfield (United States) founded in 1931, and was acquired by Warburg Pincus in October 2023. Biosciences, medication delivery, and renal products are developed and marketed. The company has 38,000 employees. Baxter has completed 20 acquisitions, including AesRx, ApaTech and Caremark. Its chief executive, as recorded, is Jose E Almeida. Its website baxter.com draws about 402 thousand monthly visits. Baxter offers products and services including Infusion Pumps, Nutritional Products, and Respiratory Therapies. Its focus areas include Diversified Medical Devices and Devices. Its competitors include GE Healthcare, Medtronic and Boston Scientific; 1 of its 3 listed competitors has raised funding.

Company details

Founded in 1931 and headquartered in Deerfield, United States, products for treating hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other medical conditions are developed, manufactured, and marketed by the company. Operations are divided into BioScience, Medication Delivery, and Renal segments, covering recombinant proteins, intravenous solutions, infusion systems, and renal therapies. In 2023, annual revenues of 15.05 billion were recorded alongside a net loss of 2.46 billion.

  • Headquarters Deerfield, United States
  • Employees 38,000
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website baxter.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by Warburg Pincus (Oct 2023)
  • Legal Name Baxter International Inc.
Key Metrics
  • Annual Revenue
    $11.24 B (USD)
    5.72
    as on Dec 31, 2025
  • Net Profit
    -$1.05 B (USD)
    -62.4
    as on Dec 31, 2025
  • EBITDA
    $1.67 B (USD)
    -0.59
    as on Dec 31, 2025
  • Latest Funding Round
    $3.09M (USD), Grant

    May 2022

  • Investors
  • Employee Count
    38,000
  • Investments & Acquisitions
    AesRx

    & 19 more

  • Acquired by

Products & Services of Baxter

Baxter offers a comprehensive portfolio of products and services, including Infusion Pumps, Nutritional Products, and Respiratory Therapies.

Infusion Pumps
Medical Devices

Devices for delivering medications and fluids to patients

Nutritional Products
Nutritional Care

Solutions for patients unable to self-feed

Respiratory Therapies
Respiratory Care

Products to simplify breathing treatments

Apps and channels of Baxter

its YouTube channel BaxterInternational has 15.3K subscribers and 30 videos.

BaxterInternational
YouTube 15.3K subscribers 30 videos Howto & Style
Open channel

Videos from Baxter

The most watched videos on Baxter's YouTube channel, BaxterInternational (15.3K subscribers). Click a video to play it here.

Improving Access to Safe Water in Colombia
7.9K views
At the Intersection of Progress and Purpose
4.7K views
Susana Pueyo Hernandez IWD 2022
4.2K views
THIS IS WHERE
3.8K views

More on BaxterInternational.

Funding Insights of Baxter

  • Total Rounds 6
  • Last Round Grant β€” $3.09M
  • Investors Count 2

All 6 funding rounds of Baxter with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2022$3.09MGrant––
Jun 2021Grant––
Jun 2019Grant––
May 2019$1.68BDebt – Conventional––
–
Jan 2019$302,805Grant––
Jun 2012Grant––
Valuation history

4 investors in total: 4 institutional.

Investors in Baxter

Baxter has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Warburg Pincus, European Union and BMBF.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Multi-stage private equity investments are pursued across diverse sectors.
1966warburgpincus.comNew York, United States
Private equity firm focused on multiple sectors
adventinternational.comSao Paulo, Brazil
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Education and research policies are overseen by the ministry.
1955bmbf.deBerlin, Germany
Premium access

Investor details for Baxter

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Baxter

The boards of the 3 registered companies of Baxter currently have 12 directors; the longest-serving is Karuna Kapoor, appointed in 2020. 72 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Karuna Kapoor
DIN 08770423
Director06 Jul 20206 yrs 4 moBaxter Innovations And Business Solutions Private Limited
Shalini Naagar
DIN 03230079
Director29 Dec 20205 yrs 10 moBaxter India Private Limited
Suresh Kumar Surapalannair
DIN 09089354
Director05 Mar 20215 yrs 8 moBaxter Innovations And Business Solutions Private Limited
Sanju Dhawan
DIN 09224741
Director09 Jul 20215 yrs 4 moBaxter Pharmaceuticals India Private Limited
Ajay Bijani
DIN 10452933
Director04 Jan 20242 yrs 10 moBaxter India Private Limited
Anil Kumar Madugulla
DIN 10462398
Director24 Jan 20242 yrs 9 moBaxter Innovations And Business Solutions Private Limited
Abhinav Kashyap
DIN 10491768
Director14 Feb 20242 yrs 8 moBaxter Innovations And Business Solutions Private Limited
Anuranjan Naresh
DIN 02822684
Additional Director01 Oct 20242 yrs 1 moBaxter Pharmaceuticals India Private Limited, Baxter India Private Limited
Tripti Sapra
DIN 10776278
Additional Director01 Oct 20242 yrs 1 moBaxter Pharmaceuticals India Private Limited, Baxter India Private Limited
Anurag Bharatkumar Pachchigar
DIN 10776295
Additional Director01 Oct 20242 yrs 1 moBaxter Pharmaceuticals India Private Limited
Gurjeet Singh Bedi
DIN 10875091
Additional Director23 Dec 20241 yr 10 moBaxter Pharmaceuticals India Private Limited
Ashwin Prakash Upasane
DIN 11132124
Additional Director18 Jun 20251 yr 4 moBaxter Pharmaceuticals India Private Limited

People of Baxter

820 people are tracked at Baxter (298 in leadership, 10 in board & advisors, 512 in team); the tracked headcount is 38,000.

NameRoleGroup
Jose E Almeida
CEOLeadership
Sasha Davis
VP Human Resources, Baxter PharmaceuticalsLeadership
Tobi Karchmer
Chief Medical And Scientific OfficerLeadership
James Borzi
EVP & Chief Supply Chain OfficerLeadership
David Bondi
Chief Procurement OfficerLeadership
Konstantin Butskiy
Vice President, Finance - Global Financial Planning & Analysis And Global Integrated Supply ChainLeadership
Julio Rodriguez Obaldia
Plant DirectorLeadership
Shani Noel
Director, Market Access & Managed CareLeadership
Christoph Schmotz
Vice President R&d PSS & GSS | Care & Connectivity Solutions | Site Lead MunichLeadership
Muneeb Ruhi
VP Canada - Digital Health & Commercial OperationsLeadership
Simone Diorio
VP Quality Medical Products And Therapies (1700 Staff)Leadership
Graham Vonder Haar
Sr Director, Global Strategy & Analytics - PharmaceuticalsLeadership
Gaganjot Gill
Director Of Quality - Multi-site LeadershipLeadership
Bhavesh Padmani
Director, Digital Health R&dLeadership
Brit Baird
Director Regulatory Affairs And Quality AssuranceLeadership
Jeanne Mason
Evp, Chief Human Resources OfficerLeadership
Nancy Laue
Vice President, Commercial Operations - U.s. And Latin AmericaLeadership
Ronald Tee
APAC Director Of OperationsLeadership
Adrienne Babb
Director Of Commercial Training & DevelopmentLeadership
Stephen Daley
Vice President And General Manager, Baxter CardiologyLeadership

800 more people are available in the full profile.

Premium access

Complete people profiles for Baxter

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Baxter

Baxter is a publicly listed company on the NYSE with ticker symbol BAX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date10 Mar 2021
  • Listed onLSE: 0QK8
  • Listed entityBaxter International Inc.
  • Exchange sectorHealth technology
  • ISINUS0718131099
  • Share price$24.89 (+0.44% on the day) · 2026-10-13
  • Market capitalisation$12.87B
  • EPS (diluted, trailing year)$-1.93
  • Dividend yield0.16%
  • Volume (last session)3,249,507

Financials of Baxter

Figures of Baxter Pharmaceuticals India Private Limited, the primary company behind Baxter, for FY 2025. Revenue was ₹672 Cr (+20% year on year). Net profit was ₹16.49 Cr (2% margin). EBITDA was ₹98.59 Cr (15% margin). Revenue has grown at a compounded annual rate of -7% over three years and -4% over five years.

  • ₹672 CrRevenue · FY 2025 · +20% YoY
  • ₹16.49 CrNet profit · 2% margin
  • ₹98.59 CrEBITDA · 15% margin
  • ₹5.7 LakhPaid-up capital
  • 1,179Employees (provident fund records)
  • -7%Revenue CAGR, 3 years
  • -4%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$11.24B-$1.05B$1.67B
2024$10.64B-$649.0M$1.68B
2023$10.36B-$226.0M$1.89B
2022$14.51B-$2.43B$3.02B
2021$12.78B$1.28B$2.97B

Balance sheet, profit and loss, cash flow and ratios of Baxter Pharmaceuticals India Private Limited are on its company page.

Premium access

Detailed financial statements for Baxter

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Baxter

Baxter has strategically engaged in corporate development activities, having acquired 20 companies. Notable acquisitions include AesRx, ApaTech and Caremark.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Body worn sensor to remotely monitor chronic diseases vitals, EvoNexus Alum.
tosense.comSan Diego, United States2014Apr 2020β€’β€’β€’β€’
Hemostat and sealant products for surgical adhesion prevention are supplied.
seprafilm.usDeerfield, United States2009Dec 2019$350M
Non-invasive cardiac output and hemodynamic monitoring devices are developed.
cheetah-medical.comNewton, United States2001Sep 2019$230M
Medical devices are manufactured for multiple therapeutic areas.
trueprocess.comMilwaukee, United States2004Aug 2017β€’β€’β€’β€’
Developer of natural resource and energy projects in South Eastern Europe
clarisinj.comAhmedabad, India2005Jul 2017$625M
Pharmaceutical products are manufactured and distributed by Sigma Tau.
sigma-tau.itRome, Italy1957May 2015β€’β€’β€’β€’
Therapeutics for autoimmune diseases are developed by SuppreMol.
suppremol.comPlanegg, Germany2002Mar 2015$223.71M
Prophylactic treatments for sickle cell disease were developed.
aesrx.comNewton, United States2009Jul 2014β€’β€’β€’β€’
Management, surveillance and reporting software for antimicrobial stewardship and infection prevention
icnetsystems.comChicago, United States2011Jun 2014β€’β€’β€’β€’
Continuous urine output monitoring systems are developed for critical care.
flowsensemedical.comMisgav, Israel2009Sep 2013$9.5M
Premium access

Complete acquisition details for Baxter

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Baxter

15 dated milestones of Baxter across 92 years, from founding to its latest funding, stage changes and deals.

  1. Founded Baxter is founded.
  2. Funding First funding round.
  3. Acquisition Acquires FlowSense Medical.
  4. Acquisition Acquires ICNet Systems.
  5. Acquisition Acquires AesRx.
  6. Acquisition Acquires SuppreMol.
  7. Acquisition Acquires Sigma Tau.
  8. Acquisition Acquires Claris Injectables.
  9. Acquisition Acquires True Process.
  10. Acquisition Acquires Cheetah Medical.
  11. Acquisition Acquires Seprafilm.
  12. Acquisition Acquires toSense.
  13. IPO Lists on the stock exchange (IPO).
  14. Funding Latest funding round, Grant, of $3.1M.
  15. Exit Acquired by Warburg Pincus.

Competitors of Baxter

Baxter has 3 listed competitors in our database, 1 of them funded. They include GE Healthcare, Medtronic and Boston Scientific.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
gehealthcare.com1892Chicago, United States$29.13M16,700
Materials management solutions are provided for healthcare organizations.
medtronic.com1949Minneapolis, United States1,114
Medical equipment for treating over 30 chronic diseases is developed.
bostonscientific.com1979Marlborough, United States63,359
Wide range of medical devices
Premium access

Detailed competitors of Baxter

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Baxter

The website of Baxter (baxter.com) receives about 401.8K visits a month and ranks #127,908 among all websites worldwide, #3,834 in Health.

  • Monthly visits
    401.8K

    ▲ 15.6% vs previous month

  • Unique visitors
    122.2K

    per month

  • Global rank
    #127,908

    among all websites

  • Category rank
    #3,834

    Health · Health

Similar websites

Websites whose visitors overlap most with Baxter. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
abbott.com
100%
917.2K#65,577View details
baxterhealthcare.co.uk
baxterhealthcare.co.uk
96%
#2,565,472–
lilly.com
88%
4.9M#13,252View details
medtronic.com
85%
2.6M#22,622View details
hospira.com
83%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Baxter

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Diversified Medical Devices

3 companies that operate in the same segment as Baxter (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medical equipment for treating over 30 chronic diseases is developed.
1949Minneapolis, Minnesota, United StatesUSD 36.36 B95,000
Wide range of medical devices
1979Marlborough, Massachusetts, United StatesUSD 20.07 B53,000
Healthcare solutions are provided by Johnson & Johnson globally.
1886New Brunswick, New Jersey, United StatesUSD 94.18 B139,800
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Baxter

Premium access

Complete news archive for Baxter

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Baxter

Baxter was founded in 1931 and raised its 1st funding round 81 years after it was founded.

Baxter is headquartered in Deerfield, United States.

Jose E Almeida is the CEO of Baxter, as recorded in our data.

Baxter has 38,000 employees.

Annual revenue of Baxter is $11.24B as on Dec 31, 2025.

Founded in 1931 and headquartered in Deerfield, United States, products for treating hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other medical conditions are developed, manufactured, and marketed by the company. Operations are divided into BioScience, Medication Delivery, and Renal segments, covering recombinant proteins, intravenous solutions, infusion systems, and renal therapies. In 2023, annual revenues of 15.05 billion were recorded alongside a net loss of 2.46 billion.

Baxter's top competitors include GE Healthcare, Medtronic and Boston Scientific.

Baxter offers Infusion Pumps, Nutritional Products, and Respiratory Therapies.

Yes, Baxter is publicly traded on NYSE under the ticker symbol BAX.

Baxter has made 20 acquisitions, including AesRx, ApaTech, and Caremark.

Baxter has 4 investors. Key investors include Warburg Pincus, European Union, BMBF, and Advent International.

Baxter is associated with 3 legal entities: Baxter Pharmaceuticals India Private Limited, Baxter India Private Limited, Baxter Innovations And Business Solutions Private Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available